FDA Approves Vorasidenib for Adults, Pediatric Patients With Grade 2 Astrocytoma, Oligodendroglioma
August 7th 2024This marks the first FDA-approved systemic therapy for patients with grade 2 astrocytoma or oligodendroglioma with a susceptible isocitrate dehydrogenase-1 (IHD1) or IDH2 mutation.
Read More
Expert: The Definition of Alzheimer Disease is Shifting From Clinical to Biological
August 2nd 2024Edward B. Lee, MD, PhD, also describes how understanding Alzheimer disease requires the integration of multiple fields including genetics, pathology, epidemiology, pharmacology, and physiology.
Read More
CDC Recommends International Travelers Receive MMR Vaccination 2 Weeks Prior to Travel
August 2nd 2024The CDC says that even if travel is less than 2 weeks away, unvaccinated individuals should still receive a dose of the measles, mumps, and rubella vaccine for protection against the disease.
Read More
Expert: Tau Oligomers Are a Culprit in the Spread of Alzheimer Disease Pathology
August 1st 2024Tara Spires-Jones, DPhil, FMedSci, discusses how oligomeric tau clumps inside brain synapses, pointing to indirect evidence that it may be progressing through the brain by jumping between connections.
Read More
Long-Acting Injectable Form of Cabotegravir Safe for HIV Prevention in Pregnant Cisgender Women
July 29th 2024An extension of a long-acting cabotegravir study shows safety prior to and during pregnancy in cisgender women, with full results being presented at the 2024 International AIDS Conference.
Read More
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
July 23rd 2024Following President Joe Biden’s decision to step down from re-election, VP Kamala Harris has stepped into the Democratic nominee position after support and endorsements from notable delegates and the president himself.
Read More